Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1547-1555

  Li, Jia ^a,b   Gao, Jian Zhi ^a,d   Du, Jing Li ^a   Huang, Zhong Xi ^c   Wei, Li Xin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cell division cycle 20; Cell proliferation; Clinical characteristics; Hepatocellular carcinoma

Indexed keywords

CELL CYCLE PROTEIN 20; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P21; PROTEIN P53; CDC20 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL CYCLE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; MALE; MOLECULAR INTERACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX DIFFERENCE; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CDC20 PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84907457916     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2559     Document Type: Article

References (34)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
2. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007. (Pubitemid 46890874)
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Severi T, van Malenstein H, Verslype C and van Pelt JF: Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 31: 1409-1420, 2010.
5. Michielsen P and Ho E: Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 74: 4-8, 2011.
6. McGivern DR and Lemon SM: Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30: 1969-1983, 2011.
7. Fung TK and Poon RY: A roller coaster ride with the mitotic cyclins. Semin Cell Dev Biol 16: 335-342, 2005.
8. Weinstein J, Jacobsen FW, Hsu-Chen J, Wu T and Baum LG: A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol 14: 3350-3363, 1994. (Pubitemid 24132747)
9. Peters JM: Cell biology: the checkpoint brake relieved. Nature 446: 868-869, 2007.
10. Fang G, Yu H and Kirschner MW: Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell 2: 163-171, 1998. (Pubitemid 128373642)
11. Cho HJ, Lee EH, Han SH, et al: Degradation of human RAP80 is cell cycle regulated by Cdc20 and Cdh1 ubiquitin ligases. Mol Cancer Res 10: 615-625, 2012.
12. Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y and Matsuda K: CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27: 1562-1571, 2008. (Pubitemid 351347882)
13. Chang DZ, Ma Y, Ji B, et al: Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol 5: 15, 2012.
14. Kim JM, Sohn HY, Yoon SY, et al: Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 11: 473-482, 2005. (Pubitemid 40116869)
15. Espinosa AM, Alfaro A, Roman-Basaure E, et al: Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer. PloS One 8: e55975, 2013.
16. Ouellet V, Guyot MC, Le Page C, et al: Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 119: 599-607, 2006. (Pubitemid 43955714)
17. Roessler S, Jia HL, Budhu A, et al: A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70: 10202-10212, 2010.
18. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
19. Dai M, Wang P, Boyd AD, et al: Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175, 2005.
20. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
21. Huang ZX, Tian HY, Hu ZF, Zhou YB, Zhao J and Yao KT: GenCLiP: a software program for clustering gene lists by literature profiling and constructing gene co-occurrence networks related to custom keywords. BMC Bioinformatics 9: 308, 2008.
22. Adhikary S and Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645, 2005. (Pubitemid 41081267)
23. Detre S, Saclani Jotti G and Dowsett M: A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48: 876-878, 1995.
24. Früh MPM: EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice? Transl Lung Cancer Res 1: 145-146, 2012.
25. Hwang LH, Lau LF, Smith DL, et al: Budding yeast Cdc20: a target of the spindle checkpoint. Science 279: 1041-1044, 1998. (Pubitemid 28113307)
26. Kops GJ, Weaver BA and Cleveland DW: On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5: 773-785, 2005. (Pubitemid 41400777)
27. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS and Roychoudhury S: Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 28: 81-92, 2007. (Pubitemid 44942629)
28. Moura IM, Delgado ML, Silva PM, et al: High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 43: 225-231, 2013.
29. Wu WJ, Hu KS, Wang DS, et al : CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med 11: 142, 2013.
30. Yeong FM, Lim HH, Padmashree CG and Surana U: Exit from mitosis in budding yeast: biphasic inactivation of the Cdc28-Clb2 mitotic kinase and the role of Cdc20. Mol Cell 5: 501-511, 2000.
31. Huang HC, Shi J, Orth JD and Mitchison TJ: Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16: 347-358, 2009.
32. Wang Z, Wan L, Zhong J, et al: Cdc20: a potential novel therapeutic target for cancer treatment. Curr Pharm Des 19: 3210-3214, 2013.
33. Bunz F, Dutriaux A, Lengauer C, et al: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998. (Pubitemid 28538613)
34. Wells J, Boyd KE, Fry CJ, Bartley SM and Farnham PJ: Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20: 5797-5807, 2000. (Pubitemid 30613029)